vTv Therapeutics Inc. Additional Paid in Capital, Common Stock
vTv Therapeutics Inc. (VTVT) had Additional Paid in Capital, Common Stock of $394.20 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-06
- 2026-06-30: Additional Paid in Capital, Common Stock $394.20M.
- 2026-03-31: Additional Paid in Capital, Common Stock $392.48M.
- 2025-12-31: Additional Paid in Capital, Common Stock $391.09M.
- 2025-09-30: Additional Paid in Capital, Common Stock $390.06M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $394.20M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $392.48M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $391.09M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $390.06M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $313.59M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $312.70M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $311.88M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $311.06M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $307.75M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $306.89M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $256.33M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $254.91M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $254.48M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $254.08M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $254.76M 10-K · filed 2024-03-13 | $253.74M 10-K · filed 2023-03-06 |
| 2022-09-30 | $253.45M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $243.77M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $238.67M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $238.19M 10-K · filed 2023-03-06 | |
| 2021-09-30 | $236.56M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $224.46M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $217.65M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $209.16M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $201.24M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $198.63M 10-Q · filed 2020-08-03 | |
| 2020-03-31 | $190.20M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $183.86M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $175.99M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $167.13M 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $162.25M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $150.59M 10-K · filed 2020-02-21 | |
| 2018-09-30 | $144.62M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $134.59M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $128.80M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $127.68M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $127.04M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $126.08M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $125.12M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $124.21M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $122.84M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $122.14M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $119.50M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $117.69M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $117.13M 10-Q · filed 2015-11-13 |